Error: Could not add to watchlist. X
+ Watchlist

Enzon Pharmaceuticals Inc

ENZN:US
OTC US
0.290
USD
0.010
3.50%
As of 11:15 AM EDT 6/29/2017
Open
0.273
Day Range
0.273 - 0.290
Volume
11,501
Previous Close
0.280
52Wk Range
0.220 - 0.378
1 Yr Return
3.56%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.273
Day Range
0.273 - 0.290
Volume
11,501
Previous Close
0.280
52Wk Range
0.220 - 0.378
1 Yr Return
3.56%
YTD Return
-20.60%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.053
Market Cap (m USD)
12.380
Shares Outstanding (m)
44.215
Price/Sales (TTM)
1.96
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-1.28%
% Price Change
-1.43%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapeutics to treat life-threatening diseases. The Company has developed several products, including PEG-INTRON. Enzon's product-focused strategy includes a drug development program that leverages its PEG modification and single-chain antibody (SCA) technologies.
Address
20 Kingsbridge Road
Piscataway, NJ 08854
United States
Phone
1-732-980-4500
  • Andrew Rackear
    CEO/Secretary
  • Richard L Feinstein
    VP:Finance/CFO
Show More